North China Pharmaceutical Company.Ltd (SHA:600812)

China flag China · Delayed Price · Currency is CNY
4.480
+0.130 (2.99%)
Jun 12, 2026, 3:00 PM CST
Market Cap7.69B -26.3%
Revenue (ttm)8.82B -10.8%
Net Income161.04M -3.2%
EPS0.09 -2.3%
Shares Out 1.72B
PE Ratio47.58
Forward PEn/a
Dividend0.04 (0.80%)
Ex-Dividend DateJun 11, 2026
Volume14,514,800
Open4.350
Previous Close4.350
Day's Range4.330 - 4.480
52-Week Range4.300 - 7.460
Beta0.24
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical pharmaceuticals; and biological, agricultural, and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China. [Read more]

Sector Healthcare
Founded 1992
Employees 9,972
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600812
Full Company Profile

Financial Performance

In 2025, SHA:600812's revenue was 9.24 billion, a decrease of -6.36% compared to the previous year's 9.87 billion. Earnings were 183.06 million, an increase of 44.15%.

Financial Statements